Search Results - "Riordan, William J."

5445936 Method for non-competitive binding assays : Piran Uri; Riordan William J; Livshin Laurie A Sharon, MA, United States assigned to Ciba Corning Diagnostics Corp

Get full text

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma by Reece, Donna E, Sullivan, Dan, Lonial, Sagar, Mohrbacher, Ann F, Chatta, Gurkamal, Shustik, Chaim, Burris, Howard III, Venkatakrishnan, Karthik, Neuwirth, Rachel, Riordan, William J, Karol, Michael, von Moltke, Lisa L, Acharya, Milin, Zannikos, Peter, Keith Stewart, A

“…Purpose Characterize bortezomib pharmacokinetics/pharmacodynamics in relapsed myeloma patients after single and repeat intravenous administration at two doses…”
Get full text

William J. Riordan, president and CEO of St. Vincent's Health Services, Bridgeport, Conn., received the American College of Healthcare Executives Senior-Level Healthcare Executive Regent's Award by Roszak, Dennis J

Get full text

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors by Dees, E. Claire, O’Neil, Bert H., Lindley, Celeste M., Collichio, Frances, Carey, Lisa A., Collins, Jason, Riordan, William J., Ivanova, Anastasia, Esseltine, Dixie, Orlowski, Robert Z.

“…Purpose Pre-clinical studies combining the proteasome inhibitor bortezomib with anthracyclines have shown enhanced anti-tumor activity. We conducted a phase I…”
Get full text

Dissociation rate constant of the biotin-streptavidin complex by Piran, U, Riordan, W J

“…We measured the dissociation rate constants of the biotin/streptavidin and biotin/egg avidin complexes by following the release of radiolabeled biotin from the…”
Get more information

Bortezomib Improves Endothelial Thromboresistance Via Induction of KLF Transcription Factors by Hiroi, Toyoko, Deming, Clayton B, Zhao, Haige, Hansen, Baranda S, Arkenbout, Elisabeth K, Myers, Thomas J, Riordan, William J, McDevitt, Michael A, Rade, Jeffrey J

“…Background: Patients with multiple myeloma (MM) are at high risk for venothromboembolic events (VTE). Recent studies, however, suggest that MM patients treated…”
Get full text

New noncompetitive immunoassays of small analytes by Piran, U, Riordan, W J, Livshin, L A

“…We developed a novel noncompetitive immunoassay format for monoepitopic analytes and describe here a model assay for triiodothyronine (T3), performed on Ciba…”
Get more information

Effect of hapten heterology on thyroid hormone immunoassays by Piran, U, Riordan, W J, Silbert, D R

“…We examined the effects of hapten heterology on triiodothyronine (T3) and thyroxine (T4) immunoassays configured with protein-conjugated diiodothyronine (T2),…”
Get more information

ON THE INTERPOLATION OF OPERATIONS by RIORDAN, WILLIAM J

Get full text

Credits, clients and awards

Get full text